Karyopharm Therapeutics Inc
$ 8.66
1.17%
16 Apr - close price
- Market Cap 192,971,000 USD
- Current Price $ 8.66
- High / Low $ 8.94 / 8.42
- Stock P/E N/A
- Book Value -16.00
- EPS -18.16
- Next Earning Report 2026-05-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.42 %
- ROE -8.91 %
- 52 Week High 10.99
- 52 Week Low 3.65
About
Karyopharm Therapeutics Inc., a pharmaceutical company, is dedicated to the discovery, development and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is headquartered in Newton, Massachusetts.
Analyst Target Price
$11.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-12 | 2025-11-05 | 2025-08-11 | 2025-05-12 | 2025-02-19 | 2024-11-05 | 2024-08-06 | 2024-05-08 | 2024-02-29 | 2023-11-02 | 2023-08-02 | 2023-05-04 |
| Reported EPS | -5.69 | -3.82 | -4.07 | -2.77 | -3.6 | -3.9 | 0.15 | -0.32 | -0.36 | -0.3 | -0.29 | -0.3 |
| Estimated EPS | -0.2125 | -2.21 | -3.91 | -3.09 | -4.03 | -3.92 | -0.3 | -0.33 | -0.31 | -0.28 | -0.34 | -0.37 |
| Surprise | -5.4775 | -1.61 | -0.16 | 0.32 | 0.43 | 0.02 | 0.45 | 0.01 | -0.05 | -0.02 | 0.05 | 0.07 |
| Surprise Percentage | -2577.6471% | -72.8507% | -4.0921% | 10.356% | 10.67% | 0.5102% | 150% | 3.0303% | -16.129% | -7.1429% | 14.7059% | 18.9189% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-11 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -1.45 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
